The Wash U NF team happily hosted Springworks Therapeutics for a Day of NF Education in October 2024. The Wash U team shared their multidisciplinary insights into the management of all aspects of NF1 care with the Springworks team. The day included a series of lectures from the providers, an educational mock tumor board as […]
Category: News Story
Undergraduate Presents at Research Symposium
On Friday, November 9, Megan Ouyang presented her research at the Washington University Fall 2024 Undergraduate Research Symposium. Megan has been working with Dr. Jit Chatterjee on the role of the gut microbiota in controlling low-grade optic glioma growth in NF1. During the symposium, Megan discussed her findings and future research directions.
Message from the Director
As the Washington University Neurofibromatosis (NF) Center enters its third decade of facilitating collaborations between clinicians and scientists, we celebrate the accomplishments of our members and the progress made towards personalizing our medical management of individuals living with NF. Over the past year, we have witnessed continued expansion of both our clinical and research programs, […]
Nf1 Gene Mutations Disrupt Brain Cell Plasticity and Motor Learning in Mice
In collaboration with Dr. Michelle Monje at Stanford University, a team of researchers in the Washington University NF Center (Drs. Gutmann and Pan) recently published in Nature Neuroscience. This work sought to understand how NF1 mutations affect oligodendrocyte precursor cells (OPCs). OPCs are actively dividing cells in the brain that give rise to oligodendrocytes, which provide […]
Banbury Center hosts first Cognition and Behavior in NF1 meeting
The Banbury Center at Cold Spring Harbor Laboratory hosted a focused meeting on Cognition and Behavior in NF1 on October 20-23, 2024. Sponsored by Penny’ FlightTM, the goal of this meeting was to identify gaps in our understanding of these common problems in NF1 and to chart a course forward. Leveraging expertise from laboratory scientists […]
Vaishali Mulchandani awarded fellowship from the Center of Regenerative Medicine Distinguished Postdoctoral Scholars Program
The Center of Regenerative Medicine (CRM) Distinguished Postdoctoral Scholars Program aims to train researchers to make significant contributions in the field of regenerative medicine through an interdisciplinary approach. Fellows are paired with a CRM faculty mentor to conduct research on projects aligned with key areas such as cell fate engineering and regenerative therapeutics. This one-year […]
Dru named Research Staff Employee of the Quarter!
The NF Center celebrates Dru Jenkins on being named Research Staff Employee of the Quarter for the first quarter of FY25! Dru is an absolutely wonderful employee. She is always ready to help with a smile and without her, the Gutmann Lab would NOT function. Her selflessness, organizational skills, and ability to care for others, […]
Dr. Yunshuo “Caroline” Tang Receives Five-Year Grant from the National Institutes of Health
Dr. Yunshuo “Caroline” Tang, MD, PhD, (Assistant Professor, Washington University) was recently awarded a five-year grant from the National Institute of Health to study the extrinsic and intrinsic mechanisms of vision loss in a mouse model of Nf1-associated optic pathway glioma (Nf1-OPG). Dr. Tang will study how extrinsic inflammatory insults and intrinsic abnormalities in cyclic AMP […]
Dr. Sheel Pathak Promoted to Associate Professor in Neurology
Dr. Sheel Pathak MD, was recently promoted to the rank of Associate Professor in the Department of Neurology. This is a major milestone in the career of a clinical faculty member at Washington University, signifying excellence in patient care, resident and student education. Dr. Pathak provides general neurologic care for patients with a variety of […]
Maternal obesogenic diet operates at the tumor cell of origin to increase incidence and decrease latency of NF1 optic pathway glioma
Children with NF1 are at risk for developing brain tumors in the optic pathway (optic pathway gliomas, OPGs), which can cause vision loss and endocrine problems. However, it is currently unclear which children with NF1 will develop these tumors, or how severe their disease will become. Using mouse models of NF1, the Brossier Lab recently identified […]
Washington University NF Center Designated as a Comprehensive NF 1 and Schwannomatosis Center
Letter Summary from Children’s Tumor Foundation Driven by the NF patient community, Children’s Tumor Foundation (CTF), with guidance from its Clinical Care Advisory Board (CCAB), developed a Designation System to assist families in identifying potential clinics that might meet specific patient needs. Based on other rare disease clinic designation models, CTF and the CCAB established […]
Welcome to the Gutmann Lab, Lori!
Lori Forster graduated from Georgia State University in 2022 with a PhD in Neuroscience. Her PhD thesis was on regulation of the hyperpolarization activated cyclic nucleotide gated ion channel 2 (HCN2) by post-translational modification, SUMO, in inflammatory pain. She recently joined the Gutmann laboratory as a Post-Doctoral Research Associate, where she will focus on defining […]
NF Family Day 2024 Exceeds Expectations
On Saturday July 20th, the Washington University NF Center hosted its 2nd Annual NF Family Day for our patients and their families. Held at Grants Farm in St. Louis, MO, participants had the opportunity to learn about IEPs, transition to adulthood, and educational apps from a licensed Occupational Therapist. As an added bonus, they also […]
Yunshuo “Caroline” Tang Promoted to Assistant Professor
Dr. Yunshuo “Caroline” Tang, MD, PhD, was recently promoted to the rank of Assistant Professor in the Departments of Neurology and Ophthalmology. This is a major milestone in the career of a faculty member at Washington University, signifying excellence in research and outstanding clinical contributions. Dr. Tang is an emerging leader in the investigation of […]
Susan Maloney Promoted to Associate Professor in Psychiatry
Susan E. Maloney, Director of the IDDRC Animal Behavior Subunit, was recently promoted to the rank of Associate Professor in the Department of Psychiatry. This is a major milestone in the career of a faculty member at Washington University, signifying excellence in research, recognition at a national level, and outstanding administrative and educational contributions to […]
NF Center Director Given Mentor of the Year Award
David H. Gutmann, MD, PhD, Director of the Washington University NF Center, was bestowed with the 2024 Mentor of the Year Award from the Institute for Informatics, Data Science and Bioinformatics (I2DB). Dr. Gutmann has been faculty of the Master’s Program in Bioinformatics and Informatic Sciences since its inception, and has mentored over ten graduate […]
Welcome to the Gutmann Lab, Vaishali!
Vaishali Mulchandani graduated from the Indian Institute of Science Education and Research, Kolkata (IISER-Kolkata) in 2023 with a PhD in Biological Sciences. Her PhD thesis was focused on understanding the importance of Connexin 43 (Cx43) trafficking and enhanced gap junctional intercellular communication formation in ovarian cancer development and metastasis. She has recently joined the Gutmann […]
Dr. Angela Hirbe Promoted to Associate Professor with Tenure
Angela C. Hirbe, the Director of the Adult NF Clinical Program, was recently promoted to the rank of Associate Professor with tenure in the Division of Medical Oncology. This is a major milestone in the career of a faculty member at Washington University, signifying excellence in research, recognition at a national level, and outstanding clinical […]
Understanding the Potential of Early-Cancer Detection Using Liquid Biopsy in Patients With Hereditary Cancer Syndromes
In this American Society of Clinical Oncology (ASCO) Daily News article, Dr. Angela Hirbe and her colleagues discuss the current data for using liquid biopsies (blood test) to attempt to diagnose cancer early. Their team is working hard to make this a reality for NF1 patients! You can read the full article here.
Epilepsy drug prevents brain tumors in mice with NF1
Study lays groundwork for clinical trial aimed at preventing brain tumors in children with NF1. A drug used to treat children with epilepsy prevents brain tumor formation and growth in two mouse models of neurofibromatosis type 1 (NF1), according to a study by researchers at Washington University School of Medicine in St. Louis. NF1 is […]